

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.02576294 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.93200539 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.69395813 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.31295639 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16929882 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.15232501 |
| 7 | vocalization behavior (GO:0071625) | 5.04793397 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.94458771 |
| 9 | glutamate secretion (GO:0014047) | 4.94044615 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.76687788 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67531455 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.66957600 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.61119356 |
| 14 | protein localization to synapse (GO:0035418) | 4.40189767 |
| 15 | exploration behavior (GO:0035640) | 4.37639711 |
| 16 | cellular potassium ion homeostasis (GO:0030007) | 4.34158461 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.30404375 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 4.27050650 |
| 19 | sodium ion export (GO:0071436) | 4.24266104 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 4.22564687 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.20691379 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.15501263 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.03420516 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.03385347 |
| 25 | proline transport (GO:0015824) | 4.01639790 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.95922166 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 3.92595922 |
| 28 | dendritic spine morphogenesis (GO:0060997) | 3.82574790 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 3.75658438 |
| 30 | long-term memory (GO:0007616) | 3.75167303 |
| 31 | amino acid import (GO:0043090) | 3.70859128 |
| 32 | neuronal action potential propagation (GO:0019227) | 3.66465775 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 3.60930602 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.59804342 |
| 35 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.59209374 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.58754679 |
| 37 | regulation of synaptic plasticity (GO:0048167) | 3.57315712 |
| 38 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55890233 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.54530323 |
| 40 | neuron-neuron synaptic transmission (GO:0007270) | 3.53343581 |
| 41 | activation of protein kinase A activity (GO:0034199) | 3.50857803 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.47904574 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.47002893 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.46992667 |
| 45 | regulation of ARF protein signal transduction (GO:0032012) | 3.45772804 |
| 46 | cell communication by electrical coupling (GO:0010644) | 3.44651666 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.39808361 |
| 48 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.39602696 |
| 49 | dendrite morphogenesis (GO:0048813) | 3.37630019 |
| 50 | neuron recognition (GO:0008038) | 3.34284725 |
| 51 | L-amino acid import (GO:0043092) | 3.32246934 |
| 52 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.31892042 |
| 53 | long-term synaptic potentiation (GO:0060291) | 3.29199568 |
| 54 | cerebellar granule cell differentiation (GO:0021707) | 3.26229396 |
| 55 | axonal fasciculation (GO:0007413) | 3.23834251 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22578157 |
| 57 | vesicle transport along microtubule (GO:0047496) | 3.21794389 |
| 58 | neurotransmitter transport (GO:0006836) | 3.18856831 |
| 59 | * neuromuscular process controlling balance (GO:0050885) | 3.18099423 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.17364477 |
| 61 | protein localization to endosome (GO:0036010) | 3.15402434 |
| 62 | regulation of neurotransmitter secretion (GO:0046928) | 3.11466243 |
| 63 | cellular sodium ion homeostasis (GO:0006883) | 3.10597899 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.10435049 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.08988415 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.08199272 |
| 67 | regulation of vesicle fusion (GO:0031338) | 3.07569776 |
| 68 | response to auditory stimulus (GO:0010996) | 3.05937596 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03713520 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.03249689 |
| 71 | innervation (GO:0060384) | 3.00593568 |
| 72 | dendritic spine organization (GO:0097061) | 3.00356648 |
| 73 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00280716 |
| 74 | membrane depolarization during action potential (GO:0086010) | 2.99390593 |
| 75 | glycine transport (GO:0015816) | 2.99357226 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.98675093 |
| 77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.96185161 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 2.95068877 |
| 79 | behavioral fear response (GO:0001662) | 2.94832549 |
| 80 | behavioral defense response (GO:0002209) | 2.94832549 |
| 81 | potassium ion import (GO:0010107) | 2.94105740 |
| 82 | membrane depolarization (GO:0051899) | 2.93749232 |
| 83 | establishment of nucleus localization (GO:0040023) | 2.93671407 |
| 84 | adenosine receptor signaling pathway (GO:0001973) | 2.93628185 |
| 85 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.93326248 |
| 86 | response to histamine (GO:0034776) | 2.91774343 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 2.90789785 |
| 88 | nerve growth factor signaling pathway (GO:0038180) | 2.90742874 |
| 89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.86592187 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.84380162 |
| 91 | regulation of synaptic transmission (GO:0050804) | 2.84042454 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 2.82833228 |
| 93 | potassium ion homeostasis (GO:0055075) | 2.82349867 |
| 94 | positive regulation of fibroblast migration (GO:0010763) | 2.82241459 |
| 95 | learning (GO:0007612) | 2.81924750 |
| 96 | positive regulation of dendritic spine development (GO:0060999) | 2.81767435 |
| 97 | regulation of dendritic spine development (GO:0060998) | 2.81533019 |
| 98 | chemosensory behavior (GO:0007635) | 2.80300888 |
| 99 | positive regulation of synaptic transmission (GO:0050806) | 2.79681315 |
| 100 | long term synaptic depression (GO:0060292) | 2.75282009 |
| 101 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.74881287 |
| 102 | positive regulation of Rap GTPase activity (GO:0032854) | 2.74340105 |
| 103 | neuronal ion channel clustering (GO:0045161) | 2.72840441 |
| 104 | fear response (GO:0042596) | 2.72300096 |
| 105 | alanine transport (GO:0032328) | 2.72134918 |
| 106 | synaptic transmission (GO:0007268) | 2.72097710 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.71944019 |
| 108 | macrophage activation involved in immune response (GO:0002281) | 2.68927273 |
| 109 | barbed-end actin filament capping (GO:0051016) | 2.63949213 |
| 110 | signal complex assembly (GO:0007172) | 2.62654361 |
| 111 | positive regulation of neurotransmitter transport (GO:0051590) | 2.61163060 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.54100395 |
| 113 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.52515073 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.51188241 |
| 115 | regulation of early endosome to late endosome transport (GO:2000641) | 2.50801261 |
| 116 | positive regulation of protein dephosphorylation (GO:0035307) | 2.46793293 |
| 117 | mannose metabolic process (GO:0006013) | 2.44720588 |
| 118 | regulation of ARF GTPase activity (GO:0032312) | 2.43190773 |
| 119 | regulation of Rap GTPase activity (GO:0032317) | 2.42118430 |
| 120 | cell-cell junction maintenance (GO:0045217) | 2.42035518 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.40618245 |
| 122 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.38506827 |
| 123 | negative regulation of cell killing (GO:0031342) | 2.38506827 |
| 124 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.38141982 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.37790868 |
| 126 | cortical actin cytoskeleton organization (GO:0030866) | 2.34279937 |
| 127 | mating behavior (GO:0007617) | 2.33490087 |
| 128 | regulation of beta-amyloid formation (GO:1902003) | 2.33026214 |
| 129 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.26517832 |
| 130 | cellular response to catecholamine stimulus (GO:0071870) | 2.22995152 |
| 131 | cellular response to monoamine stimulus (GO:0071868) | 2.22995152 |
| 132 | regulation of synapse maturation (GO:0090128) | 2.20299748 |
| 133 | acidic amino acid transport (GO:0015800) | 2.19537737 |
| 134 | dopamine receptor signaling pathway (GO:0007212) | 2.19321875 |
| 135 | positive regulation of macrophage cytokine production (GO:0060907) | 2.17879033 |
| 136 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.15618137 |
| 137 | stress fiber assembly (GO:0043149) | 2.13727524 |
| 138 | response to peptidoglycan (GO:0032494) | 2.13566340 |
| 139 | central nervous system myelination (GO:0022010) | 2.12745270 |
| 140 | axon ensheathment in central nervous system (GO:0032291) | 2.12745270 |
| 141 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.11466928 |
| 142 | cortical cytoskeleton organization (GO:0030865) | 2.08905624 |
| 143 | response to muramyl dipeptide (GO:0032495) | 2.08579297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.83519986 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89192009 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.88152158 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86136987 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84344628 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.79462358 |
| 7 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.68560154 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59136050 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59136050 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.58455329 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49193041 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45238319 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43726509 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43237773 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37342226 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.35102059 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.32957285 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26668542 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.25450045 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17050765 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15072433 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.14400872 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12671410 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09947486 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09226186 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00392282 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95331394 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87753615 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86915478 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86853845 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73370464 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68520453 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60290985 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59392984 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58896797 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55154745 |
| 37 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53065394 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50871779 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48662157 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44503837 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43365628 |
| 42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42694178 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.42574881 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42218369 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41540728 |
| 46 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40941044 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34125443 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33360088 |
| 49 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33120889 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33096942 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31300847 |
| 52 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31249480 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30898222 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30436820 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29596991 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27907923 |
| 57 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27587603 |
| 58 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.27373176 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27154611 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26861691 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26720585 |
| 62 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26486308 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24988225 |
| 64 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24771559 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24648901 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23966035 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23792810 |
| 68 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23681653 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22812256 |
| 70 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22555004 |
| 71 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20988977 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19700441 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18678269 |
| 74 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15147923 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15003161 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14852360 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14214663 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13857092 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13236589 |
| 80 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11575271 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11425869 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11384123 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10113688 |
| 84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09546866 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09072591 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08889592 |
| 87 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07920231 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07640456 |
| 89 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07184419 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06899569 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06860984 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06116462 |
| 93 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05489120 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05401906 |
| 95 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05208341 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04969702 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04943576 |
| 98 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04774040 |
| 99 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03933265 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03740917 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03476565 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03438520 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02767023 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 1.02726542 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01995186 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01073772 |
| 107 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00977377 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00953005 |
| 109 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00862680 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00457655 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00322165 |
| 112 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99484802 |
| 113 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98938447 |
| 114 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98351296 |
| 115 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98023391 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97729248 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97554727 |
| 118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96494647 |
| 119 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.94682336 |
| 120 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94280749 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94161930 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93421434 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92322646 |
| 124 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.91402186 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91283593 |
| 126 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91257605 |
| 127 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91234950 |
| 128 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91200569 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91064168 |
| 130 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90253490 |
| 131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90096311 |
| 132 | MYC_22102868_ChIP-Seq_BL_Human | 0.89280704 |
| 133 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89263768 |
| 134 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89263768 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89238582 |
| 136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88993890 |
| 137 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87773097 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87121707 |
| 139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85915714 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85886641 |
| 141 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85811157 |
| 142 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85443389 |
| 143 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84236639 |
| 144 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83764685 |
| 145 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83141136 |
| 146 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.82729126 |
| 147 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81197256 |
| 148 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.80090968 |
| 149 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79177122 |
| 150 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78938859 |
| 151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.78907700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.52527775 |
| 2 | MP0003880_abnormal_central_pattern | 4.68212489 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.25360874 |
| 4 | MP0004270_analgesia | 3.75296874 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.41819191 |
| 6 | MP0009745_abnormal_behavioral_response | 3.31374572 |
| 7 | MP0002064_seizures | 3.15805202 |
| 8 | MP0009046_muscle_twitch | 2.85868211 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.80917954 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.78301287 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.77505105 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.70756331 |
| 13 | MP0004858_abnormal_nervous_system | 2.59821740 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.45949505 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.37953410 |
| 16 | MP0001486_abnormal_startle_reflex | 2.37301852 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.30859435 |
| 18 | MP0002272_abnormal_nervous_system | 2.29547606 |
| 19 | MP0002822_catalepsy | 2.22893717 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.19128282 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.15161427 |
| 22 | MP0002736_abnormal_nociception_after | 2.08454075 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.00586583 |
| 24 | MP0003329_amyloid_beta_deposits | 1.98799661 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.97368519 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.96192710 |
| 27 | MP0003436_decreased_susceptibility_to | 1.93777724 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.92823709 |
| 29 | MP0001970_abnormal_pain_threshold | 1.92083449 |
| 30 | MP0008569_lethality_at_weaning | 1.91396368 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.86433520 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.79313805 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.77058323 |
| 34 | MP0000778_abnormal_nervous_system | 1.75541581 |
| 35 | MP0002184_abnormal_innervation | 1.65897245 |
| 36 | MP0006082_CNS_inflammation | 1.62491836 |
| 37 | MP0009840_abnormal_foam_cell | 1.62272808 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.59030381 |
| 39 | MP0003879_abnormal_hair_cell | 1.53910509 |
| 40 | MP0004510_myositis | 1.52287196 |
| 41 | MP0000955_abnormal_spinal_cord | 1.50993159 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.49552415 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.49132447 |
| 44 | MP0005409_darkened_coat_color | 1.48881204 |
| 45 | MP0004885_abnormal_endolymph | 1.46983258 |
| 46 | MP0004924_abnormal_behavior | 1.45263555 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.45263555 |
| 48 | MP0003075_altered_response_to | 1.44888154 |
| 49 | MP0003787_abnormal_imprinting | 1.43865845 |
| 50 | MP0003633_abnormal_nervous_system | 1.43561780 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.40304870 |
| 52 | MP0003091_abnormal_cell_migration | 1.38310678 |
| 53 | MP0001984_abnormal_olfaction | 1.37847915 |
| 54 | MP0009278_abnormal_bone_marrow | 1.35383187 |
| 55 | MP0001958_emphysema | 1.33975172 |
| 56 | MP0002066_abnormal_motor_capabilities/c | 1.32461580 |
| 57 | MP0002419_abnormal_innate_immunity | 1.30838199 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.29726374 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.28292802 |
| 60 | MP0008260_abnormal_autophagy | 1.26285229 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.24742850 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.24217440 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.22897293 |
| 64 | MP0000604_amyloidosis | 1.22333885 |
| 65 | MP0003724_increased_susceptibility_to | 1.21980884 |
| 66 | MP0003303_peritoneal_inflammation | 1.21821400 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.21274475 |
| 68 | MP0004947_skin_inflammation | 1.18677348 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.18412146 |
| 70 | MP0003631_nervous_system_phenotype | 1.15215075 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.14827477 |
| 72 | MP0005387_immune_system_phenotype | 1.13577674 |
| 73 | MP0001790_abnormal_immune_system | 1.13577674 |
| 74 | MP0003283_abnormal_digestive_organ | 1.11040311 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.09230993 |
| 76 | MP0000751_myopathy | 1.07038008 |
| 77 | * MP0002152_abnormal_brain_morphology | 1.06920493 |
| 78 | MP0005451_abnormal_body_composition | 1.05046792 |
| 79 | MP0005025_abnormal_response_to | 1.04741643 |
| 80 | MP0000343_altered_response_to | 1.02871880 |
| 81 | MP0001849_ear_inflammation | 1.02867711 |
| 82 | MP0003279_aneurysm | 1.01611565 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.00531498 |
| 84 | MP0001348_abnormal_lacrimal_gland | 1.00332868 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 0.98854032 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.95767954 |
| 87 | MP0002090_abnormal_vision | 0.93233114 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.92673016 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.92339982 |
| 90 | * MP0003634_abnormal_glial_cell | 0.90945905 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.90277622 |
| 92 | MP0008004_abnormal_stomach_pH | 0.89917866 |
| 93 | MP0008874_decreased_physiological_sensi | 0.88734075 |
| 94 | MP0002229_neurodegeneration | 0.87521571 |
| 95 | MP0001177_atelectasis | 0.86060746 |
| 96 | MP0003122_maternal_imprinting | 0.84877264 |
| 97 | MP0005671_abnormal_response_to | 0.84737767 |
| 98 | MP0001835_abnormal_antigen_presentation | 0.82742001 |
| 99 | MP0001905_abnormal_dopamine_level | 0.82019372 |
| 100 | MP0005165_increased_susceptibility_to | 0.81316926 |
| 101 | MP0003632_abnormal_nervous_system | 0.79048187 |
| 102 | * MP0003690_abnormal_glial_cell | 0.78718394 |
| 103 | MP0004142_abnormal_muscle_tone | 0.76774880 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.76481519 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.76063940 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.75540401 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.75212980 |
| 108 | MP0000685_abnormal_immune_system | 0.75130579 |
| 109 | MP0000920_abnormal_myelination | 0.73209391 |
| 110 | MP0002723_abnormal_immune_serum | 0.72485913 |
| 111 | MP0004085_abnormal_heartbeat | 0.70456240 |
| 112 | MP0009785_altered_susceptibility_to | 0.70382345 |
| 113 | MP0005535_abnormal_body_temperature | 0.70044557 |
| 114 | MP0002133_abnormal_respiratory_system | 0.69943668 |
| 115 | MP0005388_respiratory_system_phenotype | 0.69943668 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.67825620 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.67791888 |
| 118 | MP0008872_abnormal_physiological_respon | 0.67696780 |
| 119 | MP0005166_decreased_susceptibility_to | 0.67432182 |
| 120 | MP0001963_abnormal_hearing_physiology | 0.67411575 |
| 121 | MP0002420_abnormal_adaptive_immunity | 0.66735131 |
| 122 | MP0003828_pulmonary_edema | 0.66476859 |
| 123 | MP0001819_abnormal_immune_cell | 0.66257408 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.63966906 |
| 125 | MP0005499_abnormal_olfactory_system | 0.63812988 |
| 126 | MP0005394_taste/olfaction_phenotype | 0.63812988 |
| 127 | MP0000747_muscle_weakness | 0.63293167 |
| 128 | MP0003045_fibrosis | 0.62980277 |
| 129 | MP0004742_abnormal_vestibular_system | 0.62971333 |
| 130 | MP0005551_abnormal_eye_electrophysiolog | 0.62664408 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.62562823 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.58502366 |
| 133 | MP0004233_abnormal_muscle_weight | 0.58113146 |
| 134 | MP0002752_abnormal_somatic_nervous | 0.57725658 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.57491044 |
| 136 | MP0004484_altered_response_of | 0.56279994 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.54851803 |
| 138 | MP0001664_abnormal_digestion | 0.54748777 |
| 139 | MP0005310_abnormal_salivary_gland | 0.52080661 |
| 140 | MP0004130_abnormal_muscle_cell | 0.51794402 |
| 141 | * MP0003861_abnormal_nervous_system | 0.51378446 |
| 142 | MP0010769_abnormal_survival | 0.51112991 |
| 143 | MP0002089_abnormal_postnatal_growth/wei | 0.50452718 |
| 144 | MP0001943_abnormal_respiration | 0.49757775 |
| 145 | MP0001485_abnormal_pinna_reflex | 0.49444244 |
| 146 | MP0000631_abnormal_neuroendocrine_gland | 0.47850464 |
| 147 | MP0010768_mortality/aging | 0.46648861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.77414135 |
| 2 | Myokymia (HP:0002411) | 6.37230668 |
| 3 | Focal seizures (HP:0007359) | 5.35608722 |
| 4 | Visual hallucinations (HP:0002367) | 5.00143994 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.32514915 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.30943791 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.06680499 |
| 8 | Atonic seizures (HP:0010819) | 3.97739003 |
| 9 | Febrile seizures (HP:0002373) | 3.89863501 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.83453246 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.83453246 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.83453246 |
| 13 | Absence seizures (HP:0002121) | 3.77931270 |
| 14 | Action tremor (HP:0002345) | 3.72434205 |
| 15 | Dialeptic seizures (HP:0011146) | 3.50024069 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.48553206 |
| 17 | Papilledema (HP:0001085) | 3.44782706 |
| 18 | Mutism (HP:0002300) | 3.37443680 |
| 19 | Ankle clonus (HP:0011448) | 3.24062768 |
| 20 | Postural instability (HP:0002172) | 3.20001712 |
| 21 | Genetic anticipation (HP:0003743) | 3.17994136 |
| 22 | Depression (HP:0000716) | 3.17654804 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.11320879 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.08759384 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.07120543 |
| 26 | Dysmetria (HP:0001310) | 2.99882189 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 2.95008009 |
| 28 | Truncal ataxia (HP:0002078) | 2.90611534 |
| 29 | Hemiplegia (HP:0002301) | 2.89133693 |
| 30 | Broad-based gait (HP:0002136) | 2.89117982 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.87558490 |
| 32 | Dysdiadochokinesis (HP:0002075) | 2.87049601 |
| 33 | Poor eye contact (HP:0000817) | 2.83601375 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 2.80740240 |
| 35 | Diplopia (HP:0000651) | 2.79875541 |
| 36 | Abnormality of binocular vision (HP:0011514) | 2.79875541 |
| 37 | Abnormal social behavior (HP:0012433) | 2.73671687 |
| 38 | Impaired social interactions (HP:0000735) | 2.73671687 |
| 39 | Impaired smooth pursuit (HP:0007772) | 2.67997076 |
| 40 | Amblyopia (HP:0000646) | 2.67499992 |
| 41 | Ventricular fibrillation (HP:0001663) | 2.65233086 |
| 42 | Loss of speech (HP:0002371) | 2.64103577 |
| 43 | Hemiparesis (HP:0001269) | 2.60702265 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.60389914 |
| 45 | Axonal loss (HP:0003447) | 2.59682374 |
| 46 | Stereotypic behavior (HP:0000733) | 2.58525282 |
| 47 | Urinary urgency (HP:0000012) | 2.57142471 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.56315789 |
| 49 | Drooling (HP:0002307) | 2.53018693 |
| 50 | Excessive salivation (HP:0003781) | 2.53018693 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.52829419 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.52543173 |
| 53 | Pointed chin (HP:0000307) | 2.49634618 |
| 54 | Anxiety (HP:0000739) | 2.48195553 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46152688 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.45188354 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45173114 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45173114 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45173114 |
| 60 | Nuclear cataract (HP:0100018) | 2.43177240 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.42448042 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42448042 |
| 63 | Peripheral hypomyelination (HP:0007182) | 2.42343385 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.37209187 |
| 65 | Apathy (HP:0000741) | 2.36802696 |
| 66 | Megalencephaly (HP:0001355) | 2.35686277 |
| 67 | Insomnia (HP:0100785) | 2.33047942 |
| 68 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.31879934 |
| 69 | Bradykinesia (HP:0002067) | 2.29412093 |
| 70 | Inappropriate behavior (HP:0000719) | 2.28835102 |
| 71 | Intention tremor (HP:0002080) | 2.27957959 |
| 72 | Spastic gait (HP:0002064) | 2.27794476 |
| 73 | Torticollis (HP:0000473) | 2.26760837 |
| 74 | Scanning speech (HP:0002168) | 2.22661162 |
| 75 | Neuronal loss in central nervous system (HP:0002529) | 2.20265907 |
| 76 | Annular pancreas (HP:0001734) | 2.19662372 |
| 77 | Distal upper limb amyotrophy (HP:0007149) | 2.19119765 |
| 78 | Upper limb amyotrophy (HP:0009129) | 2.19119765 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18722699 |
| 80 | Amyloidosis (HP:0011034) | 2.18483101 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.17270039 |
| 82 | Disinhibition (HP:0000734) | 2.16859632 |
| 83 | Progressive inability to walk (HP:0002505) | 2.14215175 |
| 84 | Dysmetric saccades (HP:0000641) | 2.11901263 |
| 85 | Diminished motivation (HP:0000745) | 2.10301507 |
| 86 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05262098 |
| 87 | Absent speech (HP:0001344) | 2.04519387 |
| 88 | Fetal akinesia sequence (HP:0001989) | 2.04482970 |
| 89 | Rapidly progressive (HP:0003678) | 2.03611312 |
| 90 | Focal dystonia (HP:0004373) | 2.03473503 |
| 91 | Tetraplegia (HP:0002445) | 2.03171642 |
| 92 | Lower limb amyotrophy (HP:0007210) | 2.01307045 |
| 93 | Lower limb muscle weakness (HP:0007340) | 2.01035265 |
| 94 | Ocular albinism (HP:0001107) | 2.00574781 |
| 95 | EEG with generalized epileptiform discharges (HP:0011198) | 2.00442150 |
| 96 | Agitation (HP:0000713) | 1.99421920 |
| 97 | Termporal pattern (HP:0011008) | 1.99247229 |
| 98 | Insidious onset (HP:0003587) | 1.99247229 |
| 99 | Hyperventilation (HP:0002883) | 1.96254687 |
| 100 | Bundle branch block (HP:0011710) | 1.94883470 |
| 101 | Polyphagia (HP:0002591) | 1.93806955 |
| 102 | Impaired vibratory sensation (HP:0002495) | 1.93767881 |
| 103 | Ankyloglossia (HP:0010296) | 1.93739430 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 1.93390353 |
| 105 | Slow saccadic eye movements (HP:0000514) | 1.93266913 |
| 106 | Obstructive sleep apnea (HP:0002870) | 1.93056627 |
| 107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92564036 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 1.91883761 |
| 109 | Status epilepticus (HP:0002133) | 1.90624943 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 1.89194214 |
| 111 | Hypsarrhythmia (HP:0002521) | 1.87812558 |
| 112 | Hyperacusis (HP:0010780) | 1.87386227 |
| 113 | Hand muscle atrophy (HP:0009130) | 1.85171072 |
| 114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84090071 |
| 115 | Akinesia (HP:0002304) | 1.83045855 |
| 116 | Recurrent abscess formation (HP:0002722) | 1.82595160 |
| 117 | Global brain atrophy (HP:0002283) | 1.82562554 |
| 118 | Onion bulb formation (HP:0003383) | 1.82346086 |
| 119 | Lower limb asymmetry (HP:0100559) | 1.80439690 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 1.80373847 |
| 121 | Hyperparathyroidism (HP:0000843) | 1.80007994 |
| 122 | Memory impairment (HP:0002354) | 1.78657055 |
| 123 | Broad face (HP:0000283) | 1.78629499 |
| 124 | Cellulitis (HP:0100658) | 1.78334979 |
| 125 | Abnormality of saccadic eye movements (HP:0000570) | 1.77766168 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 1.77217258 |
| 127 | Psychosis (HP:0000709) | 1.76058804 |
| 128 | Abnormality of salivation (HP:0100755) | 1.75461378 |
| 129 | Abnormality of the periventricular white matter (HP:0002518) | 1.74834676 |
| 130 | Incomplete penetrance (HP:0003829) | 1.74833749 |
| 131 | Increased circulating renin level (HP:0000848) | 1.74422192 |
| 132 | Vacuolated lymphocytes (HP:0001922) | 1.74336747 |
| 133 | Hypoventilation (HP:0002791) | 1.73664948 |
| 134 | Rigidity (HP:0002063) | 1.73615038 |
| 135 | Distal lower limb amyotrophy (HP:0008944) | 1.73349774 |
| 136 | Abnormal EKG (HP:0003115) | 1.71419529 |
| 137 | Personality changes (HP:0000751) | 1.71125084 |
| 138 | Craniofacial dystonia (HP:0012179) | 1.70404039 |
| 139 | Thin bony cortex (HP:0002753) | 1.69645058 |
| 140 | Iris hypopigmentation (HP:0007730) | 1.69224564 |
| 141 | Macroorchidism (HP:0000053) | 1.68463408 |
| 142 | Turricephaly (HP:0000262) | 1.67753692 |
| 143 | Dementia (HP:0000726) | 1.66903073 |
| 144 | Spastic tetraparesis (HP:0001285) | 1.66177853 |
| 145 | Amyotrophic lateral sclerosis (HP:0007354) | 1.65982347 |
| 146 | Aqueductal stenosis (HP:0002410) | 1.65487515 |
| 147 | Glomerulonephritis (HP:0000099) | 1.64987986 |
| 148 | Gingivitis (HP:0000230) | 1.63431762 |
| 149 | Decreased motor nerve conduction velocity (HP:0003431) | 1.62067116 |
| 150 | Distal sensory impairment (HP:0002936) | 1.62010895 |
| 151 | Vertebral compression fractures (HP:0002953) | 1.61906863 |
| 152 | Clonus (HP:0002169) | 1.61523845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.47786957 |
| 2 | MAP3K9 | 4.26995307 |
| 3 | EPHA4 | 4.26288798 |
| 4 | MARK1 | 3.00463056 |
| 5 | KSR2 | 2.67159749 |
| 6 | DAPK2 | 2.57524496 |
| 7 | MAP3K4 | 2.52755233 |
| 8 | RIPK4 | 2.52405571 |
| 9 | MINK1 | 2.52264808 |
| 10 | PAK6 | 2.45081336 |
| 11 | PRKD3 | 2.22642856 |
| 12 | NTRK2 | 2.18784185 |
| 13 | CAMKK1 | 2.03869019 |
| 14 | MAP2K7 | 1.87462471 |
| 15 | KSR1 | 1.82283802 |
| 16 | SIK2 | 1.81715059 |
| 17 | NTRK1 | 1.77609015 |
| 18 | ERN1 | 1.74687900 |
| 19 | MAP3K13 | 1.72896335 |
| 20 | FES | 1.67580864 |
| 21 | CDK5 | 1.58283653 |
| 22 | MAP3K2 | 1.56046502 |
| 23 | DAPK1 | 1.54475443 |
| 24 | STK38 | 1.48313558 |
| 25 | MAP2K4 | 1.45005694 |
| 26 | MAP3K12 | 1.41329640 |
| 27 | MAP3K11 | 1.38098611 |
| 28 | ARAF | 1.36566215 |
| 29 | BLK | 1.32606909 |
| 30 | TYRO3 | 1.31924747 |
| 31 | TNIK | 1.30727964 |
| 32 | PLK2 | 1.30560102 |
| 33 | TAOK1 | 1.26938275 |
| 34 | IRAK3 | 1.25873001 |
| 35 | PRPF4B | 1.18523426 |
| 36 | MARK2 | 1.10412492 |
| 37 | MAPK13 | 1.06563944 |
| 38 | GRK5 | 1.05434802 |
| 39 | PRKCG | 1.04351052 |
| 40 | PRKCH | 1.02994218 |
| 41 | ALK | 1.02216854 |
| 42 | TESK1 | 1.01668330 |
| 43 | MAPK12 | 1.01497040 |
| 44 | RIPK1 | 0.99482196 |
| 45 | CAMK1 | 0.98180093 |
| 46 | RET | 0.98085443 |
| 47 | UHMK1 | 0.94842142 |
| 48 | JAK1 | 0.93804123 |
| 49 | TAOK2 | 0.93268827 |
| 50 | SIK1 | 0.93025727 |
| 51 | CAMKK2 | 0.92362304 |
| 52 | TYK2 | 0.91465149 |
| 53 | RAF1 | 0.91079450 |
| 54 | STK11 | 0.90397032 |
| 55 | LMTK2 | 0.86833305 |
| 56 | PHKG1 | 0.86195589 |
| 57 | PHKG2 | 0.86195589 |
| 58 | MAP4K1 | 0.82008148 |
| 59 | SGK3 | 0.81705716 |
| 60 | CDK15 | 0.81078907 |
| 61 | CAMK1G | 0.81046779 |
| 62 | CDK18 | 0.80911503 |
| 63 | CAMK2A | 0.80695238 |
| 64 | IRAK2 | 0.80410063 |
| 65 | PTK2B | 0.79699773 |
| 66 | PDK1 | 0.79464561 |
| 67 | MAP3K1 | 0.77774495 |
| 68 | CDK19 | 0.77612711 |
| 69 | SCYL2 | 0.76601599 |
| 70 | CDK14 | 0.75607968 |
| 71 | SGK1 | 0.73940483 |
| 72 | MAP3K7 | 0.73901434 |
| 73 | FGR | 0.73269726 |
| 74 | LATS2 | 0.72796091 |
| 75 | SGK494 | 0.72444635 |
| 76 | SGK223 | 0.72444635 |
| 77 | PDPK1 | 0.71967698 |
| 78 | CAMK1D | 0.71720605 |
| 79 | CAMK2B | 0.71348971 |
| 80 | EPHB1 | 0.71008252 |
| 81 | PAK3 | 0.70408865 |
| 82 | ZAP70 | 0.70103072 |
| 83 | TTN | 0.69725711 |
| 84 | CDK11A | 0.69711355 |
| 85 | SGK2 | 0.69587690 |
| 86 | TBK1 | 0.69560739 |
| 87 | DMPK | 0.69144916 |
| 88 | MAP3K3 | 0.68061125 |
| 89 | CSK | 0.67910211 |
| 90 | MAP3K14 | 0.65613818 |
| 91 | LIMK1 | 0.65453744 |
| 92 | MAP2K3 | 0.65453380 |
| 93 | ROCK2 | 0.63689952 |
| 94 | SMG1 | 0.62695931 |
| 95 | JAK2 | 0.62381844 |
| 96 | PNCK | 0.60694410 |
| 97 | DYRK1A | 0.60589079 |
| 98 | FYN | 0.60532618 |
| 99 | CSNK1G2 | 0.60453874 |
| 100 | NEK6 | 0.60098661 |
| 101 | CDC42BPA | 0.59060445 |
| 102 | PRKG2 | 0.57487375 |
| 103 | EEF2K | 0.57401602 |
| 104 | MAPK7 | 0.57401252 |
| 105 | TGFBR2 | 0.54565422 |
| 106 | BMX | 0.53195806 |
| 107 | CSF1R | 0.52405027 |
| 108 | RPS6KA3 | 0.50504469 |
| 109 | PRKCZ | 0.49806750 |
| 110 | CAMK2G | 0.47201429 |
| 111 | TRIB3 | 0.47157996 |
| 112 | MAPK10 | 0.46502863 |
| 113 | RPS6KA2 | 0.46272080 |
| 114 | CAMK4 | 0.46166049 |
| 115 | SYK | 0.45867774 |
| 116 | PDGFRB | 0.43818305 |
| 117 | IRAK4 | 0.43394063 |
| 118 | TNK2 | 0.42734851 |
| 119 | DDR2 | 0.41541346 |
| 120 | FER | 0.40468935 |
| 121 | BMPR2 | 0.39966289 |
| 122 | PRKCE | 0.39417178 |
| 123 | PDGFRA | 0.38258866 |
| 124 | MAP2K1 | 0.37381100 |
| 125 | ICK | 0.36488991 |
| 126 | HCK | 0.32613858 |
| 127 | CAMK2D | 0.32028305 |
| 128 | DAPK3 | 0.31384473 |
| 129 | PRKD2 | 0.31085635 |
| 130 | SRC | 0.30678268 |
| 131 | PINK1 | 0.29949419 |
| 132 | PKN2 | 0.29646117 |
| 133 | CASK | 0.29062909 |
| 134 | PRKCB | 0.28372426 |
| 135 | MOS | 0.27962595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.11617424 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.89522864 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.53592646 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.47342154 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43683744 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.33986938 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.31518047 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.29173663 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20592244 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.18435227 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.04721204 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.01458811 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87488304 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.85932637 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82313742 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80141722 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71908975 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68612703 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58469179 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58372776 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53158582 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.49175201 |
| 23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48070982 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.47886665 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43118935 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39796514 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37650998 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.35835963 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35587609 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34602766 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.33997576 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30227949 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28517421 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.26489975 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25084897 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23550135 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.21906932 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21204949 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17677491 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16023986 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14784510 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14110783 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11656155 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.07716495 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02729648 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00954647 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99797388 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99054905 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98303725 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96647734 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96062671 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95967878 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93746641 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.92895769 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92836791 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89075186 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.88921405 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.87048834 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85530490 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85156804 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83166619 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83150298 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82283781 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80583134 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.78882369 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76683852 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76637125 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76125309 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75874891 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75837872 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75571522 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74730469 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74404573 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74155086 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73819216 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73451184 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72439334 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71616411 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71452760 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70866434 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69557324 |
| 82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69273918 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69087584 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66993835 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66890282 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.66154634 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66043658 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64712549 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64533400 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63807860 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63166394 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61687397 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61493541 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61045766 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60788192 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.57073125 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.56643114 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56621109 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55039439 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53165967 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49114164 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49063414 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.48177612 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47173924 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46865923 |
| 106 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46569292 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46261510 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45640245 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45463178 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44441177 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.44215278 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.44060777 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.43607964 |
| 114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43423970 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43328211 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.43151873 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.42774582 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42034289 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41686738 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41264307 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41002024 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40599238 |

